ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $939 | +51.7% | 34,942 | +101.4% | 0.01% | +66.7% |
| Q2 2023 | $619 | +56.3% | 17,347 | +11.2% | 0.01% | +50.0% |
| Q1 2023 | $396 | -37.4% | 15,602 | 0.0% | 0.00% | -42.9% |
| Q4 2022 | $633 | -99.9% | 15,602 | 0.0% | 0.01% | +16.7% |
| Q3 2022 | $515,000 | -17.6% | 15,602 | +14.7% | 0.01% | 0.0% |
| Q1 2022 | $625,000 | -35.4% | 13,600 | -6.8% | 0.01% | -33.3% |
| Q4 2021 | $968,000 | +6.3% | 14,600 | 0.0% | 0.01% | +12.5% |
| Q3 2021 | $911,000 | -24.6% | 14,600 | 0.0% | 0.01% | -27.3% |
| Q2 2021 | $1,209,000 | +24.9% | 14,600 | 0.0% | 0.01% | +10.0% |
| Q1 2021 | $968,000 | -21.6% | 14,600 | -9.3% | 0.01% | -16.7% |
| Q4 2020 | $1,235,000 | +78.2% | 16,100 | 0.0% | 0.01% | +50.0% |
| Q3 2020 | $693,000 | -9.1% | 16,100 | -8.8% | 0.01% | -11.1% |
| Q2 2020 | $762,000 | +12.9% | 17,655 | -24.8% | 0.01% | 0.0% |
| Q1 2020 | $675,000 | -60.6% | 23,476 | -13.1% | 0.01% | -52.6% |
| Q4 2019 | $1,712,000 | +120.9% | 27,000 | -1.8% | 0.02% | +111.1% |
| Q3 2019 | $775,000 | +6.3% | 27,500 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $729,000 | – | 27,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |